Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Salisbury RA, Curto-Garcia N, O'Sullivan J, Chen F, Polzella P, Godfrey AL, Russell J, Knapper S, Willan J, Frewin R, Joshi S, Arami S, Burns S, Teh CH, Wadelin F, Dhanapal J, Neelakantan P, Milojkovic D, Psaila B, Szydlo R, Francis S, Cargo C, Jain M, McGregor A, Wallis L, Duncombe A, Hussein H, Dyer P, Munro L, Bond L, McMullin MF, Somervaille TCP, Garg M, Sekhar M, Harrison C, Mead AJ, Innes AJ. Salisbury RA, et al. Among authors: neelakantan p. Leukemia. 2021 Aug;35(8):2424-2430. doi: 10.1038/s41375-021-01143-2. Epub 2021 Feb 12. Leukemia. 2021. PMID: 33580204 Free PMC article. No abstract available.
The transformative journey of chronic myeloid leukemia.
Neelakantan P, Mead A. Neelakantan P, et al. Int J Hematol Oncol. 2018 Aug 28;7(1):IJH07. doi: 10.2217/ijh-2018-0008. eCollection 2018 Mar. Int J Hematol Oncol. 2018. PMID: 30302237 Free PMC article. No abstract available.
Real-world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.
Milojkovic D, Cross NCP, Ali S, Byrne J, Campbell G, Dignan FL, Drummond M, Huntly B, Marshall S, McMullin MF, Neelakantan P, Raghavan M, Sivakumaran M, Tighe J, Wandroo F, Willis F, Glen F, Fildes L, Collington SJ, Ryan J, Clark RE, Mead AJ. Milojkovic D, et al. Among authors: neelakantan p. Br J Haematol. 2021 Jan;192(1):62-74. doi: 10.1111/bjh.16733. Epub 2020 May 24. Br J Haematol. 2021. PMID: 32449159 Free article.
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.
Booth S, Willan J, Wong H, Khan D, Farnell R, Hunter A, Eyre T, Katz H, Dungarwalla M, Chen L, Browning J, Polzella P, Gray N, Neelakantan P, Dhillon EK, Dutton D, Sternberg A, Prideaux S, Collins GP, Peniket A. Booth S, et al. Among authors: neelakantan p. Eur J Haematol. 2020 Oct;105(4):476-483. doi: 10.1111/ejh.13469. Epub 2020 Jul 13. Eur J Haematol. 2020. PMID: 32544294 Free PMC article.
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study.
Mead AJ, Butt NM, Nagi W, Whiteway A, Kirkpatrick S, Rinaldi C, Roughley C, Ackroyd S, Ewing J, Neelakantan P, Garg M, Tucker D, Murphy J, Patel H, Bains R, Chiu G, Hickey J, Harrison C, Somervaille TCP. Mead AJ, et al. Among authors: neelakantan p. Ther Adv Hematol. 2022 Mar 28;13:20406207221084487. doi: 10.1177/20406207221084487. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35371428 Free PMC article.
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
McLornan DP, Godfrey AL, Green A, Frewin R, Arami S, Brady J, Butt NM, Cargo C, Ewing J, Francis S, Garg M, Harrison C, Innes A, Khan A, Knapper S, Lambert J, Mead A, McGregor A, Neelakantan P, Psaila B, Somervaille TCP, Woodley C, Nangalia J, Cross NCP, McMullin MF; BSH Committee. McLornan DP, et al. Among authors: neelakantan p. Br J Haematol. 2024 Jan;204(1):127-135. doi: 10.1111/bjh.19164. Epub 2023 Nov 6. Br J Haematol. 2024. PMID: 37932932 No abstract available.
The management of myelofibrosis: A British Society for Haematology Guideline.
McLornan DP, Psaila B, Ewing J, Innes A, Arami S, Brady J, Butt NM, Cargo C, Cross NCP, Francis S, Frewin R, Garg M, Godfrey AL, Green A, Khan A, Knapper S, Lambert J, McGregor A, McMullin MF, Nangalia J, Neelakantan P, Woodley C, Mead A, Somervaille TCP, Harrison CN; BSH Committee. McLornan DP, et al. Among authors: neelakantan p. Br J Haematol. 2024 Jan;204(1):136-150. doi: 10.1111/bjh.19186. Epub 2023 Dec 1. Br J Haematol. 2024. PMID: 38037886 No abstract available.
161 results